Therapeutic Options for Achieving Realistic Management Goals in your IBS Patients: An Update for Primary Care

Title:

Therapeutic Options for Achieving Realistic Management Goals in your IBS Patients: An Update for Primary Care

Topic: Gastroenterology
Relevant Terms: Primary Care
Primary Audience: Primary care clinicians, including physicians, physician assistants, nurse practitioners, nurses and others who diagnose, treat, and manage patients with IBS.
Launch Date: 30-Jan-18
Credits: 1.25 AMA PRA Category 1 Credits
1.25 ANCC contact hours
Expiration Date: 29-Jan-19
Curriculum Name: Managing a Patient with Irritable Bowel Syndrome

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Identify symptom criteria for the diagnosis of irritable bowel syndrome (IBS) and its subtypes by eliciting a thorough patient history and applying clinical symptom criteria
  2. Implement available screening and diagnostic tools for the diagnosis of IBS and recognize indications for referral to specialist care
  3. Articulate the range of treatment options (both pharmacologic and non-pharmacologic therapies) for patients with IBS
  4. Interpret consensus guidelines for the management of IBS
  5. Summarize evidence-based guidelines for effective monitoring of patients with IBS
  6. Establish strategies to improve communication between patients and healthcare providers concerning their symptoms of IBS and its management in order to improve outcomes

    Faculty

    Horst Christian Weber, MD
    Course Director
    Department of Medicine, Gastroenterology
    Boston Medical Center
    Assistant Professor of Medicine
    Boston University School of Medicine
    Boston, MA
     
    Associated Chief and Clinical Director,
    Gastroenterology and Hepatology
    VA Boston Healthcare System
    Jamaica Plain, MA
    Albena Halpert, MD
    Consultant Faculty
    Assistant Professor
    Section of Gastroenterology
    Boston University School of Medicine
    Boston, MA
    DISCLOSURE POLICY STATEMENT
    Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
     
    Faculty Disclosures
    Dr. Christian Weber, Course Director, is a consultant for Allergan and Karos Pharmaceuticals.
     
    Dr. Albena Halpert, Consultant Faculty, is a consultant for Allergan.
     
    Off-Label Discussions
    The unlabeled/investigational uses of commercial products will be discussed in this activity.
    For IBS-D off-label discussion of probiotics, loperamide, diphenoxylate-atropine, smooth muscle antispasmodics, tricyclic antidepressants, antibiotics and bile salts (cholestyramine) will be included. For IBS-C off-label discussion of fiber supplementation, laxatives, plecanatide (CIC), antispasmodics, SSRI/SNRI and behavioral therapies.
     
    Planning Committee Disclosures
     
    Rachel Bereiweriso, NP, MSN, Nursing Course Advisor for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
     
    Michael Burk, Senior Program Manager for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
     
    Carmela Townsend, Lead Nurse Planner for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
     
    Christopher Drury, consultant medical editor for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
     
    Dana Frazier, Program and Grant Manager for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
     
    Bret Lashner, MD, Co-Course Director for Boston University School of Medicine's Office of Continuing Medical Education and Professor of Medicine at the Cleveland Clinic, has no financial relationships to disclose.
     
    DISCLAIMER
    THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
     
    ACCREDITATION STATEMENT
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Boston University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
    Contact Hours: 1.25, all of which are eligible for pharmacology credit.

    HOW TO RECEIVE CREDIT
    In order to successfully complete this activity, you are required to review the entire course content and successfully complete the post-test and evaluation. CME and CNE credit will be awarded provided a score of 70% or better is achieved. A certificate of credit will be available for immediate download to those who successfully complete the examination.
     
    Release Date: 1/31/18
    Expiration Date: 1/30/19
    Date of Most Recent Review: Not Applicable
    Program Code: E.IBS17
     
    For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
    To view Boston University's Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.

    © Trustees of Boston University, 2018
     
    COMMERCIAL SUPPORT
    This continuing medical education activity is supported by independent educational grants from Allergan, Ironwood Pharmaceuticals Inc., and Salix Pharmaceuticals Inc.

    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above
     
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above.